Abstract
Photodynamic therapy is an evolving treatment modality for cancer owing to its non-invasive approach. This mode of therapy depends on the dynamic interaction of light, oxygen and a photoactive drug to induce oxidative damage to affected cells. This apparently simple technique could be complicated by several factors, mainly contributed by the nature of the physicochemical properties of the photoactive drug, variation in light source and exposure time, as well as tumor physiological environment. This review covers a brief history on the use of various fluorophores in photodynamic therapy, successful marketed formulations and the factors affecting the treatment modalities. The potential of nanostructures as effective delivery carriers with improved photodynamic efficacy is also elaborated. A thorough understanding of the chemistry of photoactive drugs, characteristics of the delivery carriers and light irradiation parameters will enable optimal efficacy of photodynamic therapy.
Keywords: Photodynamic therapy, photosensitizers, nanocarriers, optimized delivery, carcinoma, cancer.
Current Pharmaceutical Design
Title:Implications of Photophysical and Physicochemical Factors on Successful Application of Photodynamic Therapy
Volume: 23 Issue: 40
Author(s): Shubhajit Paul, Paul Wan Sia Heng and Lai Wah Chan*
Affiliation:
- Department of Pharmacy, 18 Science Drive 4, National University of Singapore, 117543,Singapore
Keywords: Photodynamic therapy, photosensitizers, nanocarriers, optimized delivery, carcinoma, cancer.
Abstract: Photodynamic therapy is an evolving treatment modality for cancer owing to its non-invasive approach. This mode of therapy depends on the dynamic interaction of light, oxygen and a photoactive drug to induce oxidative damage to affected cells. This apparently simple technique could be complicated by several factors, mainly contributed by the nature of the physicochemical properties of the photoactive drug, variation in light source and exposure time, as well as tumor physiological environment. This review covers a brief history on the use of various fluorophores in photodynamic therapy, successful marketed formulations and the factors affecting the treatment modalities. The potential of nanostructures as effective delivery carriers with improved photodynamic efficacy is also elaborated. A thorough understanding of the chemistry of photoactive drugs, characteristics of the delivery carriers and light irradiation parameters will enable optimal efficacy of photodynamic therapy.
Export Options
About this article
Cite this article as:
Paul Shubhajit, Heng Wan Sia Paul and Chan Wah Lai *, Implications of Photophysical and Physicochemical Factors on Successful Application of Photodynamic Therapy, Current Pharmaceutical Design 2017; 23 (40) . https://dx.doi.org/10.2174/1381612823666170307104032
DOI https://dx.doi.org/10.2174/1381612823666170307104032 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular Profiling - An Essential Technology Enabling Personalized Medicine in Breast Cancer
Current Drug Targets Subcellular Analysis of the Platelet Proteome
Current Proteomics Thyroid Cancer and Nodules in Graves’ Disease: A Single Center Experience
Endocrine, Metabolic & Immune Disorders - Drug Targets A Review of Diabetes Mellitus and Exposure to the Environmental Toxicant Cadmium with an Emphasis on Likely Mechanisms of Action
Current Diabetes Reviews Review of Selected Patents for Cancer Therapy Targeting Tumor Angiogenesis
Recent Patents on Anti-Cancer Drug Discovery Cholinergic Receptors as Target for Cancer Therapy in a Systems Medicine Perspective
Current Molecular Medicine Human Model Neurons in Studies of Brain Cell Damage and Neural Repair
Current Molecular Medicine Defining and Managing Expectations for Early Immunotherapy Cancer Trials
Reviews on Recent Clinical Trials Evidence that Bergapten, Independently of its Photoactivation, Enhances p53 Gene Expression and Induces Apoptosis in Human Breast Cancer Cells
Current Cancer Drug Targets Determination of Dysregulated miRNA Expression Levels by qRT-PCR after the Application of Usnic Acid to Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Topotecan Is a Substrate for Multidrug Resistance Associated Protein 4
Current Drug Metabolism Cardiomyocyte-Specific TβR2 Knockout Mice are More Susceptible to Cardiac Hypertrophy Induced by Adrenergic Agonist Stimulation
Current Molecular Medicine Glycogen Synthase Kinase-3 - An Overview of An Over-Achieving Protein Kinase
Current Drug Targets Anti-Cancer Drug Design Using Natural and Synthetic Pharmacophores
Current Organic Chemistry Therapeutic Modulation of Growth Factors and Cytokines in Regenerative Medicine
Current Pharmaceutical Design Chronic Inflammation and Oxidative Stress as a Major Cause of Age- Related Diseases and Cancer
Recent Patents on Inflammation & Allergy Drug Discovery Chronobiology of the Neuroimmunoendocrine System and Aging
Current Pharmaceutical Design Chemical Biology: Past, Present and Future
Current Chemical Biology Role of Polyamines in Breast Cancer Growth, Development and Progression
Current Cancer Therapy Reviews Increased Tumor Oxygenation and Drug Uptake During Anti-Angiogenic Weekly Low Dose Cyclophosphamide Enhances the Anti-Tumor Effect of Weekly Tirapazamine (Supplementry Material)
Current Cancer Drug Targets